Literature DB >> 3208548

Conditions affecting the results of susceptibility testing for the quinolone compounds.

S M Smith1, R H Eng, C E Cherubin.   

Abstract

The quinolone class of compounds was studied for conditions which might affect susceptibility results. These compounds included amifloxacin, ciprofloxacin, difloxacin, enoxacin, norfloxacin, ofloxacin, and RO 23-6240. Ciprofloxacin, a representative quinolone, was found to have rapid bactericidal activity, equivalent to that of gentamicin, in contrast to the slower activity of a cephalosporin, cefotaxime. Test conditions that might affect susceptibility test results included divalent magnesium and calcium cation concentrations and pH. For strains of Staphylococcus aureus, Enterobacteriaceae, and enterococcus, the effects were not large. A pH of 5.0 in general increased the minimum inhibitory concentrations (MICs) for the organisms against most carboxyquinolones, up to 8-fold, as compared to that at pH 7.4. In comparison, a similar lowering of pH caused an increased in MIC of 32-fold for gentamicin and no change for cefotaxime. Increasing the concentrations of divalent cations increased the MICs on the average of only 4-fold. Of the quinolones, difloxacin was the least affected by change in concentration of divalent cations and by pH. Such changes are not expected to greatly affect the efficacy of therapy of those members of Enterobacteriaceae which have MICs much less than 0.1 micrograms/ml, but might diminish therapeutic efficacy for those organisms such as Streptococcus aureus with MICs of 1.0 microgram/ml or higher.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3208548     DOI: 10.1159/000238584

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


  12 in total

1.  Activity of the investigational fluoroquinolone finafloxacin against ciprofloxacin-sensitive and -resistant Acinetobacter baumannii isolates.

Authors:  Paul G Higgins; Will Stubbings; Hilmar Wisplinghoff; Harald Seifert
Journal:  Antimicrob Agents Chemother       Date:  2010-01-25       Impact factor: 5.191

2.  Comparative in vitro and in vivo activities of six new monofluoroquinolone and difluoroquinolone 3-carboxylic acids with a 7-azetidin ring substituent.

Authors:  D Gargallo-Viola; M Esteve; M Moros; R Coll; M A Xicota; C de Andres; R Roser; J Guinea
Journal:  Antimicrob Agents Chemother       Date:  1990-12       Impact factor: 5.191

3.  In vitro spectrum of activity of finafloxacin, a novel, pH-activated fluoroquinolone, under standard and acidic conditions.

Authors:  Will Stubbings; Pamela Leow; Goh Chee Yong; Falicia Goh; Barbara Körber-Irrgang; Michael Kresken; Rainer Endermann; Harald Labischinski
Journal:  Antimicrob Agents Chemother       Date:  2011-06-27       Impact factor: 5.191

4.  Urinary Tract Physiological Conditions Promote Ciprofloxacin Resistance in Low-Level-Quinolone-Resistant Escherichia coli.

Authors:  Guillermo Martín-Gutiérrez; Jerónimo Rodríguez-Beltrán; José Manuel Rodríguez-Martínez; Coloma Costas; Javier Aznar; Álvaro Pascual; Jesús Blázquez
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191

5.  Pharmacokinetic evaluation of ceftiofur in serum, tissue chamber fluid and bronchial secretions from healthy beef-bred calves.

Authors:  S L Halstead; R D Walker; J C Baker; R E Holland; G E Stein; J G Hauptman
Journal:  Can J Vet Res       Date:  1992-10       Impact factor: 1.310

6.  In vitro and in vivo activities of the nitroimidazole CGI 17341 against Mycobacterium tuberculosis.

Authors:  D R Ashtekar; R Costa-Perira; K Nagrajan; N Vishvanathan; A D Bhatt; W Rittel
Journal:  Antimicrob Agents Chemother       Date:  1993-02       Impact factor: 5.191

Review 7.  Impermeability to quinolones in gram-positive and gram-negative bacteria.

Authors:  L E Bryan; J Bedard
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-04       Impact factor: 3.267

8.  In vitro activities of enoxacin, enrofloxacin, sparfloxacin, and ciprofloxacin against Escherichia coli strains isolated from diarrheic lambs and kids.

Authors:  D Cid; S Piriz; J A Ruiz-Santa-Quiteria; J Valle; S Garcia; S Vadillo; R de la Fuente
Journal:  Antimicrob Agents Chemother       Date:  1994-10       Impact factor: 5.191

Review 9.  Fleroxacin. A review of its pharmacology and therapeutic efficacy in various infections.

Authors:  J A Balfour; P A Todd; D H Peters
Journal:  Drugs       Date:  1995-05       Impact factor: 9.546

Review 10.  Fluoroquinolone antimicrobial agents.

Authors:  J S Wolfson; D C Hooper
Journal:  Clin Microbiol Rev       Date:  1989-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.